Discordances in the Classification of Renal Impairment in Summaries of Product Characteristics
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Poster
- By: SALGADO, Teresa M. (IMed.UL, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal)
- Co-author(s): Arguello, B. (Department of Social Pharmacy, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal)
Benrimoj, S.I. (Graduate School of Health, University of Technology Sydney, Sydney, Australia)
Fernández-Llimós, F. (Department of Social Pharmacy, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal)
The Summaries of Product Characteristics (SmPCs) are the European official drug information sources for professionals although they have been criticized for being incomplete and confusing.
The study aimed at assessing harmonization in creatinine clearance (CrCl) limits used to define stages of renal impairment (RI) across SmPCs The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.